左氧氟沙星联合阿奇霉素治疗高龄难治性呼吸道感染的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (43 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the efficacy of Levofloxacin combined with Azithromycin in the treatment of refractory respiratory tract infections(RTI)in elderly patients.MethodsAltogether 130 cases of elderly patients with refractory RTI who were treated in our hospital from May 2015 to December 2016 were randomly selected as the object of this research and randomly divided into observation group(n=65)and control group(n=65);control group were treated with Levofloxacin;observation group were treated with combination of Levofloxacin and Azithromycin;the total effective rate,remission time of clinical symptoms and incidence of adverse reaction of two groups were compared.ResultsThe total effective rate of observation group was 98.46%,higher than that of control group(84.62%)(P<0.05);the incidence of adverse reaction of observation group was 6.15%,slightly higher than that of control group(4.62%)(P>0.05);the disappearance time of cough,fever and pulmonary rales of observation group was shorter than that of control group,P<0.05;IL-8,CRPand TNF-α levels of observation group in the 7 th treatment day were lower than those of control group;and the IL-10 level of observation group was higher than that of control group,P<0.05.ConclusionApplication of combination of Levofloxacin and Azithromycin is effective and safe in the treatment of refractory respiratory tract infections in elderly patients,which is worth popularizing in clinical practice.

Key words： Levofloxacin Azithromycin Refractory respiratory tract infections in elderly patients Clinical symptom relief time Adverse reactions

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HUANG Hui
	WAN Lin
	ZOU Huai-yu
	WAN Min-na
	WAN Jie-hua

Cite this article:

HUANG Hui,WAN Lin,ZOU Huai-yu, et al. Clinical efficacy of Levoflox acin combined with Azithromycin in the treatment of refractory respiratory tract Infections in elderly patients[J]. 中国当代医药, 2017, 24(18): 84-86转89.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I18/84

[1]	吴琼.阿奇霉素联合左氧氟沙星治疗老年难治性呼吸道感染的效果观察[J].中国医药指南，2013，11（12）：565-566.
[2]	韩英花.难治性呼吸道感染患者采用氧氟沙星联合阿奇霉素治疗的效果观察[J].中国卫生标准管理，2014，5（19）：103-105.
[3]	黄新桥，周颖兰.左氧氟沙星联合阿奇霉素治疗难治性呼吸道感染的效果观察[J].中国现代药物应用，2015，9（18）：96-97.
[4]	林海仁，符家武，郑宏林，等.纤维支气管镜下支气管肺泡灌洗术和深部吸痰术治疗难治性下呼吸道感染的疗效影响[J].中外医学研究，2013，11（19）：45-46.
[5]	冉坤，刘红，杨辉，等.帕珠沙星与左氧氟沙星治疗老年葡萄球菌下呼吸道感染的对比研究[J].重庆医学，2015，44（20）：2774-2775，2779.
[6]	郭萍，历亚，杜海军，等.氧氟沙星与左氧氟沙星及莫西沙星治疗呼吸道感染成本-效果分析[J].中华医院感染学杂志，2015，25（19）：4427-4429.
[7]	蔡金龙，曲书强.肺炎支原体下呼吸道感染的发病机制及糖皮质激素的治疗作用[J].临床儿科杂志，2015，33（6）：597-599.
[8]	杨俊智.左氧氟沙星联合阿奇霉素治疗老年难治性呼吸道感染 29 例[J].现代诊断与治疗，2014，25（9）：1990.
[9]	陈伟，凌敏.难治性下呼吸道感染患者BALF病原菌分布及药敏分析[J].临床肺科杂志，2016，21（2）：223-226.
[10]	徐瑞岭.探讨呼吸道感染患者经氧氟沙星、左氧氟沙星及莫西沙星治疗后的成本-效果[J].辽宁医学杂志，2016，30（5）：6-8.
[11]	张棽，黄尧文，郭展雯，等.罗红霉素联合左氧氟沙星在老年性呼吸道感染中的应用[J].临床和实验医学杂志，2013，12（9）：716-717，719.
[12]	高延辉，姚永江.左氧氟沙星序贯治疗慢性阻塞性肺疾病并下呼吸道感染疗效分析[J].中国基层医药，2015，22（3）：442-443.
[13]	韩红燕.注射用头孢他啶联合阿奇霉素对老年铜绿假单胞菌呼吸道感染的疗效观察[J].中国医师进修杂志，2014，37（22）：69-70.
[14]	王培香，印亚双，陈月，等.阿奇霉素对比阿莫西林-克拉维酸治疗儿童部分急性呼吸道感染临床疗效与安全性的系统评价[J].国际药学研究杂志，2016，43（4）：646-651.
[15]	顾建新.左氧氟沙星联合阿奇霉素治疗老年难治性呼吸道感染的疗效研究[J].临床合理用药杂志，2014，7（33）：3-4.